Defying Prognosis with Ivermectin for Cancer

Rick Alderson, a retired sawmill worker diagnosed with terminal colon cancer, defied doctors’ prognosis and lived for two more years with the help of ivermectin, a drug initially used for parasitic infections. Studies suggest that ivermectin has anti-cancer effects by targeting tumor stem cells, enhancing chemotherapy and radiation therapy, boosting the immune system’s response, and inhibiting cancer cell growth.

Editor’s Note: The findings surrounding ivermectin’s anti-cancer properties are intriguing and worth further investigation. With how Ivermectin was vilified in the media, especially during the height of COVID-19, it is noteworthy to mention that this miracle drug has the potential for much bigger things.

Big pharma operates in a competitive market heavily driven by profit motives. Since Ivermectin is cheaper and has a higher safety profile than cancer treatments, it will likely disrupt revenue streams that are going straight into the pocket of the few. Suppression of what could be this potentially life-saving drug cannot be tolerated. [See also: FDA Agrees to Delete Its Disinformation Regarding Ivermectin Dr. Pierre Kory Explains Why, YouTube deletes 2015 video of Nobel Prize winner Dr. Satoshi Ōmura discussing ivermectin, How Ivermectin’s success has been suppressed by mainstream media, How Public’s Confidence in Big Pharma Fuels Greed and Deception, Just how powerful is Big Pharma?, The Deep Entanglement of Big Tech, Media, and Pfizer].

Read Original Article